Attapon Cheepsattayakorn1,2*, Ruangrong Cheepsattayakorn3 and Porntep Siriwanarangsun1
1Faculty of Medicine, Western University, Pathumtani Province, Thailand 210thZonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand 3Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand.
Received: November 07, 2022; Published: December 01, 2022
Due to immunosuppression, lung or solid-organ-transplant (SOT) patients are at increased risk of infection-related morbidity and mortality, particularly SARS-CoV-2 (COVID-19) infection [1-4]. Dramatically, COVID-19 vaccination changed both immunocompetent- and immunosuppressed-persons landscape [5]. A recent study revealed that SOT recipients with receiving a third dose of COVID-19 vaccination demonstrated improvement of humoral-immune response, compared to patients with receiving two doses [6].
Citation: Attapon Cheepsattayakorn., et al. “Fourth Dose of COVID-19 Vaccination in Lung Transplant Recipients". Acta Scientific Microbiology 6.1 (2023): 01.
Copyright: © 2022 Attapon Cheepsattayakorn., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.